Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$253,124,279
+$3,961,210 QoQ
Shares Held
996,670
-2.2% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
3.19%
of 13F equity value
Holder Rank
#175
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Haverford Trust Co holds $537,648,653 across 11 Drug Manufacturers - General names. JNJ ranks #1 (47.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
996,670 | $253,124,279 | |
| 2 | LLY |
ELI LILLY & Co
|
165,960 | $199,057,419 | |
| 3 | MRK |
Merck & Co., Inc.
|
272,415 | $35,005,327 | |
| 4 | ABBV |
AbbVie Inc.
|
80,847 | $20,344,339 | |
| 5 | AMGN |
Amgen Inc
|
29,763 | $10,777,777 | |
| 6 | PFE |
Pfizer Inc
|
381,414 | $9,184,449 | |
| 7 | NVS |
Novartis AG
|
28,222 | $4,422,951 | |
| 8 | GSK |
GSK plc
|
47,770 | $2,504,103 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $253,124,279 | 996,670 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $249,163,069 | 1,019,322 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $215,083,135 | 1,039,300 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $194,386,540 | 1,048,358 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $173,000,525 | 1,132,573 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $190,346,840 | 1,147,774 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $168,669,582 | 1,166,295 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $194,657,234 | 1,201,143 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $176,870,408 | 1,210,115 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $195,824,191 | 1,237,905 | Shares | Defined | 2024-05-02 | |
| 2023-12-31 | $211,514,987 | 1,349,464 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $213,349,932 | 1,369,823 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $228,557,464 | 1,380,845 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $210,960,890 | 1,361,038 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $237,881,482 | 1,346,626 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $218,424,408 | 1,337,074 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $234,081,726 | 1,318,696 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $230,822,225 | 1,302,388 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $219,067,280 | 1,280,571 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $205,540,727 | 1,272,698 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $238,235,291 | 1,446,129 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $230,791,938 | 1,404,271 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $186,346,733 | 1,184,056 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $171,536,260 | 1,152,178 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $162,164,390 | 1,153,128 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $149,828,088 | 1,142,592 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||